Rare
lephants
Screener
Toggle theme
AbCellera Biologics Inc.
ABCL
·
Healthcare, Drug Manufacturers - General, British Columbia, Canada
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2022
FY2021
FY2020
FY2019
Total Cash from Operations:
$277.4M
Line Item
Value
% of Total
Capital Expenditures
$70.7M
25.5%
Other Investing
$205.4M
74.1%
Other Financing
$1.3M
0.5%
Net Cash Flow
$0
0.0%
Download CSV
